P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
068270
302440
H
145020
196170
A
298380

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Income from Continuing Operations
â‚©90.8B
CAGR 3-Years
28%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Income from Continuing Operations
â‚©320.9B
CAGR 3-Years
-19%
CAGR 5-Years
7%
CAGR 10-Years
10%
SK Bioscience Co Ltd
KRX:302440
Income from Continuing Operations
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Income from Continuing Operations
â‚©119B
CAGR 3-Years
27%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Income from Continuing Operations
-â‚©3.6B
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Income from Continuing Operations
-â‚©35.9B
CAGR 3-Years
12%
CAGR 5-Years
27%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
90.8B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Income from Continuing Operations amounts to 90.8B KRW.

What is PharmaResearch Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
47%

Over the last year, the Income from Continuing Operations growth was 58%. The average annual Income from Continuing Operations growth rates for PharmaResearch Co Ltd have been 28% over the past three years , 47% over the past five years .

Back to Top